Charleston, SC -- (SBWIRE) -- 09/10/2013 -- ImpressivePennyStocks.com covers several stocks on the NASDAQ and New York Stock Exchange that technically qualify as penny stocks, we typically find ones that are on the OTC Market. ImpressivePennyStocks.com issues a special report on the following stocks: MannKind Corporation (NASDAQ:MNKD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Smith & Wesson Holding Corp (NASDAQ:SWHC), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA).
MannKind Corporation (NASDAQ:MNKD) opened its last trade at the price of $5.89. Its closing price was $5.98 after gaining 2.05% for the day. The company traded with the total volume of 4.34 million shares, while its average trading volume remained 10.31 million shares. The beta of this stock stands at 1.47. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
For How Long MNKD will Fight for Profitability? Read This Trend Analysis report
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) percentage change surged 6.45% to close at $22.79 with the total traded volume of 4.32 million shares, versus average volume of 1.68 million. The 52 week range of the stock remained $1.73 - $23.49, while its day lowest price was $21.55. The share price hit the day highest price of $23.49. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.
For How Long ACAD’s Gloss will Attract Investors? Find out via this report
Smith & Wesson Holding Corp (NASDAQ:SWHC) traded on volume of 4.31 million shares in the last session against average volume of 2.74 million shares. The company started its trading session with the price of $10.43 and closed at $10.64 by scoring +3.20%. Smith & Wesson Holding Corporation engages in the manufacture and sale of firearm products in the United States and internationally. It offers firearms; handguns, including revolvers and pistols; long guns, such as sporting, bolt action, and single shot rifles; hunting rifles; black powder firearms; handcuffs and restraints; and firearm-related products and accessories.
Will SWHC Continue To Move Higher? Find Out Here
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) started its last trading session with the price of $6.37 and closed at $6.32 by scoring -1.10%. The stock traded with total volume of 4.11 million shares, while the average trading volume remained 4.50 million shares. The beta value of this stock stands at 0.21. Day range for the stock was $6.26 -$6.42. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Will ARNA Get Buyers Even After The Recent Rally? Find Out Here
About Impressive Penny Stocks:
We are different here at Impressive Penny Stocks because we care about our subscribers. You can email us any time with questions, tips, or just to say hello. We are real people and we love to hear from our loyal subscribers.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ImpressivePennyStocks.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ImpressivePennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ImpressivePennyStocks’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ImpressivePennyStocks or an offer or solicitation to buy or sell any security. Neither the owner of ImpressivePennyStocks nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. ImpressivePennyStocks makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Read Full Disclaimer at: http://impressivepennystocks.com/disclaimer/#navigation
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)